LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
Optimism for A66 Upgrade Amid Legal ChallengesBy News Team10/05/2024 Despite ongoing legal challenges, there’s optimism for a £1.5bn upgrade of the A66 corridor.The project aims to dual a significant 18-mile portion of the route to…
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026